Prism Technologies Group (PRZM) Receives Media Sentiment Score of 0.18

News stories about Prism Technologies Group (NASDAQ:PRZM) have trended somewhat positive on Saturday, Accern Sentiment Analysis reports. The research group scores the sentiment of press coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Prism Technologies Group earned a news sentiment score of 0.18 on Accern’s scale. Accern also assigned news coverage about the business services provider an impact score of 42.6609863155177 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

Shares of Prism Technologies Group (NASDAQ:PRZM) opened at 0.095 on Friday. Prism Technologies Group has a 52-week low of $0.03 and a 52-week high of $1.06. The stock’s market capitalization is $956935.00. The stock’s 50 day moving average is $0.06 and its 200 day moving average is $0.41.

TRADEMARK VIOLATION WARNING: This piece was published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this piece on another website, it was stolen and reposted in violation of U.S. & international copyright & trademark legislation. The legal version of this piece can be viewed at

About Prism Technologies Group

Prism Technologies Group, Inc, formerly Internet Patents Corporation, is engaged in the business of licensing and enforcing a portfolio of patents relating to technologies developed by it. The Company’s subsidiary is Prism Technologies, LLC (Prism). Prism has two primary operating subsidiaries: Secure Axcess, LLC and Millenium Biologix, LLC.

Receive News & Ratings for Prism Technologies Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prism Technologies Group Inc and related companies with's FREE daily email newsletter.

Leave a Reply